Onchilles Pharma Advancing Tumor-Killing Drug Candidate to the Clinic

University of Chicago spinout Onchilles Pharma plans to initiate first-in-human clinical trials next year for its lead drug candidate – which has demonstrated broad, potent, and direct tumor-killing activity. The…

This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of products and services, assist with our promotional and marketing efforts.

Accept